TLR4 functions as a receptor for resistin, an adipokine related to obesity and T2DM which has been implicated in tumorigenesis through PI3K-AKT and MAPK pathways and is suspected to confer resistance to chemotherapy in breast cancer cells [31,32,33]. Here, AKT1 is linked to breast cancer.